Zenas BioPharma Growth Metrics (2023-2025) | ZBIO

Growth Metrics Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) 442.63%-20.18%
Assets (QoQ) -8.29%-9.79%-12.19%9.87%
Capital Expenditures Growth (1y) -18.18%
Capital Expenditures (QoQ) 59.09%-75.68%
Cash & Equivalents Growth (1y) 397.90%462.36%745.67%49.46%-16.23%
Cash & Equivalents (QoQ) -21.37%-34.65%395.05%95.75%-11.19%-1.73%-12.51%9.71%
Cash from Investing Activities Growth (1y) -392,054.55%-320,731.43%249.64%
Cash from Investing Activities (QoQ) -59.09%-76,357.14%86.04%-2,209.88%-30.16%135.66%
Cash from Operations Growth (1y) -150.35%-93.96%-34.83%-32.41%
Cash from Operations (QoQ) -24.04%-62.07%-0.32%-24.13%3.90%-12.66%1.48%
EBITDA Margin (QoQ) 71,300.00
EBIT Growth (1y) -215.05%-124.48%-35.36%-38.94%-28.29%
EBIT Margin (QoQ) 73,916.00
EBIT (QoQ) -169.56%-11.30%-43.96%-3.23%-35.72%32.89%-47.77%4.68%
EBT Growth (1y) -208.37%-128.15%-21.50%-37.46%-33.40%
EBT Margin (QoQ) 79,290.00
EBT (QoQ) -169.56%-12.19%-36.61%-1.66%-46.44%40.25%-54.55%1.35%
Enterprise Value Growth (1y) 793.10%85.05%39.42%46.31%-8.63%
Enterprise Value (QoQ) 21.37%34.50%-394.14%372.36%-101.70%-165.49%-337.94%563.49%
EPS (Basic) Growth (1y) -307.44%205.61%95.53%94.84%75.70%
EPS (Basic) (QoQ) -762.81%-11.53%-35.44%79.28%437.45%-104.72%-56.25%2.40%
EPS (Weighted Average and Diluted) Growth (1y) -356.12%205.61%95.53%94.84%75.70%
EPS (Weighted Average and Diluted) (QoQ) -918.37%-11.53%-35.44%79.28%437.45%-104.72%-56.25%2.40%
FCF Margin (QoQ) 40,187.00
Free Cash Flow Growth (1y) -150.83%-93.83%-34.68%-32.41%
Free Cash Flow (QoQ) -24.18%-62.07%-0.21%-24.37%4.04%-12.61%1.48%
Net Cash Flow Growth (1y) -163.43%-524.31%-203.79%-59.39%
Net Cash Flow (QoQ) -28.59%843.46%20.05%-122.95%-204.74%-23.60%146.97%
Net Income Growth (1y) -208.37%-128.15%-20.77%-37.51%-33.40%
Net Income (QoQ) -169.56%-12.19%-36.61%-1.66%-46.44%40.61%-55.55%1.39%
Net Income towards Common Stockholders Growth (1y) -208.37%-128.15%-20.77%-37.51%-33.40%
Net Income towards Common Stockholders (QoQ) -169.56%-12.19%-36.61%-1.66%-46.44%40.61%-55.55%1.39%
Net Margin (QoQ) 79,495.00
Operating Income Growth (1y) -215.05%-124.48%-35.36%-38.94%-28.29%
Operating Income (QoQ) -169.56%-11.30%-43.96%-3.23%-35.72%32.89%-47.77%4.68%
Operating Margin (QoQ) 73,916.00
Profit After Tax Growth (1y) -208.42%-113.93%-20.86%-37.43%-33.40%
Profit After Tax (QoQ) -169.05%-13.07%-36.69%-1.59%-36.25%36.12%-55.43%1.38%
Property, Plant & Equipment (Net) Growth (1y) -4.15%-65.75%
Property, Plant & Equipment (Net) (QoQ) 26.71%-61.08%-15.28%-18.03%
Return on Assets (QoQ) -6.00-10.00-5.00
Return on Capital Employed (QoQ) -8.00-15.00-6.00
Return on Equity Growth (1y) -89.00277.00
Return on Equity (QoQ) -386.00318.00-8.00-13.00-20.00
Revenue (QoQ) 100.00%
Share-based Compensation Growth (1y) 183.45%384.14%468.74%293.55%158.04%
Share-based Compensation (QoQ) 13.16%-16.56%62.20%85.09%93.28%-1.98%12.24%21.36%
Shareholder's Equity Growth (1y) 277.73%238.43%212.60%182.98%-45.35%
Shareholder's Equity (QoQ) -11.61%-11.86%-14.37%224.47%-13.07%-9.01%-15.72%-18.03%